Introduction
Surgical site infections can have a significant effect on quality of life for the patient. They are associated with considerable morbidity and extended hospital stay. In addition, surgical site infections result in a considerable financial burden to healthcare providers. Advances in surgery and anaesthesia have resulted in patients who are at greater risk of surgical site infections being considered for surgery. In addition, increased numbers of infections are now being seen in primary care because patients are allowed home earlier following day case and fast-track surgery.
The guideline makes recommendations for prevention and management of surgical site infections based on rigorous evaluation of the best available published evidence.
The guideline will assume that prescribers will use a drug's summary of product characteristics to inform their decisions for individual patients. In addition, published identified characteristics of appropriate interactive dressings and antimicrobial products should be considered before use, Families and carers should also be given the information and support they need.
Care of young people in transition between paediatric and adult services should be planned and managed according to the best practice guidance described in 'Transition: getting it right for young people'.
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Key priorities for implementation
Information for patients and carers
Offer patients and carers clear, consistent information and advice throughout all stages of their care. This should include the risks of surgical site infections, what is being done to reduce them and how they are managed.
Preoperative phase
Do not use hair removal routinely to reduce the risk of surgical site infection.
If hair has to be removed, use electric clippers with a single-use head on the day of surgery.
Do not use razors for hair removal, because they increase the risk of surgical site infection.
Give antibiotic prophylaxis to patients before: clean surgery involving the placement of a prosthesis or implant clean-contaminated surgery contaminated surgery.
Do not use antibiotic prophylaxis routinely for clean non-prosthetic uncomplicated surgery.
Use the local antibiotic formulary and always consider potential adverse effects when choosing specific antibiotics for prophylaxis.
Consider giving a single dose of antibiotic prophylaxis intravenously on starting anaesthesia. However, give prophylaxis earlier for operations in which a tourniquet is used.
Intraoperative phase
Prepare the skin at the surgical site immediately before incision using an antiseptic (aqueous or alcohol-based) preparation: povidoneiodine or chlorhexidine are most suitable.
Cover surgical incisions with an appropriate interactive dressing at the end of the operation.
Postoperative phase
Surgical site infection NICE clinical guideline 74 Refer to a tissue viability nurse (or another healthcare professional with tissue viability expertise) for advice on appropriate dressings for the management of surgical wounds that are healing by secondary intention.
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The following guidance is based on the best available evidence. The full guideline gives details of the methods and the evidence used to develop the guidance. Hand jewellery, artificial nails and nail polish
Information for patients and carers
1.2.9
The operating team should remove hand jewellery before operations.
1.2.10
The operating team should remove artificial nails and nail polish before operations.
Antibiotic prophylaxis
Surgical site infection Give a repeat dose of antibiotic prophylaxis when the operation is longer than the half-life of the antibiotic given.
1.2.16
Give antibiotic treatment (in addition to prophylaxis) to patients having surgery on a dirty or infected wound.
1.2.17 Inform patients before the operation, whenever possible, if they will need antibiotic prophylaxis, and afterwards if they have been given antibiotics during their operation. 
Intraoperative phase
Specialist wound care services
The following recommendation has been taken unchanged from 'Guidance on the use of debriding agents and specialist wound care clinics for difficult to heal surgical wounds' (NICE technology appraisal 24).
1.4.11
Although there is no direct evidence to support the provision of specialist wound care services for managing difficult to heal surgical wounds, a structured approach to care (including preoperative assessments to identify individuals with potential wound healing problems) is required in order to improve overall management of surgical wounds. To support this, enhanced education of healthcare workers, patients and carers, and sharing of clinical expertise will be required.
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2 Notes on the scope of the guidance NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.
Groups that will be covered
All patients, both adults and children, undergoing surgical incisions through the skin. This includes minimally invasive surgery (arthroscopic, thoracoscopic and laparoscopic surgery).
Incisional infections up to 30 days post initial procedure will be covered.
Groups that will not be covered
Patients undergoing a surgical procedure that does not involve a visible surgical incision, and therefore does not result in the presence of a conventional surgical wound, for example, vaginal hysterectomy, transurethral resection of the prostate and oral surgery. In addition, procedures involving intravascular catheters, shunts, endoscopy and pin sites will not be covered. 
How this guideline was developed
Research recommendations
The Guideline Development Group has made the following recommendations for research, based on its review of evidence, to improve NICE guidance and patient care in the future. The Guideline Development Group's full set of research recommendations is detailed in the full guideline (see section 5).
Nasal decontamination
Is it cost effective to use mupirocin for nasal decontamination? In which patients is it most effective?
Why this is important
This is important as it is not clear how many surgical site infections would be prevented by treating all patients with nasal mupirocin, or whether only patients who are nasally colonised with methicillin-resistant Staphylococcus aureus should be treated. The use of mupirocin and its application is cost-and time-sensitive, apart from the concern that excessive use of mupirocin may lead to resistance. There should be further research involving large numbers of study participants undergoing different operations.
Maintaining patient homeostasis
Oxygenation
What is the value of supplemented oxygenation in the recovery room in the prevention of surgical site infection? What are the likely mechanisms of action?
Why this is important
There have been several randomised control trials (RCTs) that show a contradictory effect of supplemental oxygenation in the recovery room period, some showing benefit, some not. Two separate trials indicate that surgical site infection rates can be halved simply by increasing the amount of inspired oxygen. However, a fraction of inspired oxygen (FiO 2 ) of 0.8 cannot be achieved using a face mask, and all patients already receive an increased FiO 2 to give a haemoglobin saturation of at least 95% by their anaesthetist during the operation and in the Surgical site infection NICE clinical guideline 74 immediate postoperative period. The mechanism for improved blood oxygen carriage due to increased FiO 2 is physiologically not clear. However, this simple, cheap intervention deserves further investigation.
Perioperative blood glucose control
What are the possible benefits of improved postoperative blood glucose control on the incidence of surgical site infection? 
Why this is important
Closure methods
What types of closure methods will reduce the risk of surgical site infection?
Why this is important
Although there are many studies in the field of wound closure, there are still several areas in 
Wound dressings
What is the benefit and cost effectiveness of different types of post-surgical interactive dressings for reducing the risk of surgical site infection?
Why this is important
There are a huge number of dressings available for chronic wound care that could also be used for incisional sites. The use of island dressings compared with simple adhesive polyurethane transparent dressings is an example of a study that could be undertaken with outcomes of reductions in surgical site infections and also reductions in skin complications and improvements in final cosmetic outcomes. However, current studies are not adequate to show convincing differences. Research is also required on the effects of antiseptic-bearing dressings, placed at the end of an operation or at dressing changes. These antiseptics could include povidone-iodine, biguanides (such as chlorhexidine) or silver.
Dressings for wound healing by secondary intention
What are the most appropriate methods of chronic wound care (including alginates, foams and hydrocolloids and dressings containing antiseptics such as antimicrobial honey, cadexomer iodine or silver) in terms of management of surgical site infection as well as patient outcomes?
Why this is important
There are many small cohort studies which have examined the use of the wide range of dressings in surgical site infection management after an infected wound has been opened or after there has been separation of the wound edges after a surgical site infection. 
Information for the public
NICE has produced information for the public explaining this guideline.
We encourage NHS and voluntary sector organisations to use text from this information in their own materials about surgical site infections. 
Surgical site (wound) infection
This occurs when pathogenic organisms multiply in a wound giving rise to local signs and symptoms, for example, heat, redness, pain and swelling, and (in more serious cases) with systemic signs of fever or a raised white blood cell count. Infection in the surgical wound may prevent healing taking place so that the wound edges separate or it may cause an abscess to form in the deeper tissues.
The definitions of surgical site infection may vary between research studies but are commonly based on those described by the Centers for Disease
Control and Prevention although other valid measures have been used. For example, the ASEPSIS scoring method for postoperative wound infections and some studies which have focused only on the more serious deep and organ/space infections for which less subjective measures are available.
Differences in case definitions should be taken into account when comparing reported rates of surgical site infection.
Surgical wound classification
Clean: an incision in which no inflammation is encountered in a surgical procedure, without a break in sterile technique, and during which the respiratory, alimentary or genitourinary tracts are not entered.
Clean-contaminated: an incision through which the respiratory, alimentary, or genitourinary tract is entered under controlled conditions but with no contamination encountered.
Contaminated: an incision undertaken during an operation in which there is a major break in sterile technique or gross spillage from the gastrointestinal tract, or an incision in which acute, non-purulent inflammation is encountered. Open traumatic wounds that are more than 12-24 hours old also fall into this category.
Dirty or infected: an incision undertaken during an operation in which the viscera are perforated or when acute inflammation with pus is encountered (for example, emergency surgery for faecal peritonitis), and for traumatic wounds where treatment is delayed, there is faecal contamination, or devitalised tissue is present.
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